News
A “heavy workload” and “limited resources” have left the agency unable to meet a June 17 deadline to approve a therapy ...
1h
Zacks Investment Research on MSNIs Amarin (AMRN) Stock Outpacing Its Medical Peers This Year?Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has Amarin (AMRN) been one of those stocks this year? A quick glance at the ...
GSK plc (LSE/NYSE: GSK) today announced the launch of the Linked by Lupus: Optimal Care Initiative to help support ...
The incidence of RSV across 5 respiratory virus seasons was substantial among adult patients with high-risk underlying conditions.
Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on ...
Sage Therapeutics Inc. has found itself a buyer that bested the unsolicited acquisition offer a few months ago from fellow ...
There were some movers and shakers while we were on the show floor. Let's get caught up.
23andMe's co-founder and former chief executive, Anne Wojcicki, looks set to regain control of the business after emerging ...
The Inflation Reduction Act (IRA), signed into law in August 2022, marked a historic shift in US healthcare policy by ...
This FTSE 100 pharmaceutical giant has been hit by fears of US tariffs and litigation over a key product, but this could mean ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results